Achilles Therapeutics Statistics
Total Valuation
ACHL has a market cap or net worth of $40.32 million. The enterprise value is -$42.11 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, before market open.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ACHL has 41.10 million shares outstanding. The number of shares has increased by 1.45% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 41.10M |
| Shares Change (YoY) | +1.45% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 6.51% |
| Owned by Institutions (%) | 16.50% |
| Float | 20.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.39 |
| P/TBV Ratio | 0.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.04, with a Debt / Equity ratio of 0.04.
| Current Ratio | 6.04 |
| Quick Ratio | 5.84 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -52.12% and return on invested capital (ROIC) is -33.60%.
| Return on Equity (ROE) | -52.12% |
| Return on Assets (ROA) | -30.17% |
| Return on Capital (ROIC) | -33.60% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$311,065 |
| Employee Count | 215 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ACHL has paid $485,000 in taxes.
| Income Tax | 485,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.66% in the last 52 weeks. The beta is 1.37, so ACHL's price volatility has been higher than the market average.
| Beta (5Y) | 1.37 |
| 52-Week Price Change | +16.66% |
| 50-Day Moving Average | 1.02 |
| 200-Day Moving Average | 0.92 |
| Relative Strength Index (RSI) | 36.71 |
| Average Volume (20 Days) | 128,227 |
Short Selling Information
| Short Interest | 136,659 |
| Short Previous Month | 215,692 |
| Short % of Shares Out | 0.63% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.69 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -71.93M |
| Pretax Income | -64.01M |
| Net Income | -66.88M |
| EBITDA | -67.23M |
| EBIT | -71.93M |
| Earnings Per Share (EPS) | -$1.66 |
Full Income StatementBalance Sheet
The company has $86.05 million in cash and $3.62 million in debt, giving a net cash position of $82.43 million or $2.01 per share.
| Cash & Cash Equivalents | 86.05M |
| Total Debt | 3.62M |
| Net Cash | 82.43M |
| Net Cash Per Share | $2.01 |
| Equity (Book Value) | 103.14M |
| Book Value Per Share | 2.51 |
| Working Capital | 93.16M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$63.26 million and capital expenditures -$805,000, giving a free cash flow of -$64.07 million.
| Operating Cash Flow | -63.26M |
| Capital Expenditures | -805,000 |
| Free Cash Flow | -64.07M |
| FCF Per Share | -$1.56 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |